Federal contract award
75F40123P00397
TO DETERMINE IF THE PRESENTED PEPTIDES HAVE THE POTENTIAL OF ELICITING AN IMMUNE RESPONSE BY ACTIVATING CD4+ T CELLS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | AN41 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Sep 28, 2023 |
| Current end date | Sep 29, 2024 |
| Potential end date | Sep 29, 2024 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00001 | $-225.4K | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. |
| Sep 28, 2023 | 0 | $225.4K | TO DETERMINE IF THE PRESENTED PEPTIDES HAVE THE POTENTIAL OF ELICITING AN IMMUNE RESPONSE BY ACTIVATING CD4+ T CELLS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.